Radiofrequency ablation of retained placenta accreta after conservative management: preliminary evaluation in the pregnant ewe and in normal human placenta in vitro.
OBJECTIVE
To evaluate radiofrequency (RF) efficiency and safety for the ablation of retained placenta in humans, using a pregnant sheep model.


METHODS
Experimental study.


METHODS
Laboratory of Surgery School, Nancy, France.


METHODS
Three pregnant ewes/ten human placentas.


METHODS
Various RF procedures were tested in pregnant ewes on 50 placentomes (individual placental units). Reproducibility of the best procedure was then evaluated in a further 20 placentomes and on ten human term placentas in vitro after delivery.


METHODS
Placental tissues destruction, lesions' size, myometrial lesions.


RESULTS
Low power (100 W) and low target temperatures (60 degrees C) lead to homogenous tissue destruction, without myometrial lesion. No significant difference was observed in terms of lesion size and procedure duration for in the placentomes of pregnant ewe in vivo and in human placentas in vitro. The diameter of the ablation could be correlated with the tines deployment.


CONCLUSIONS
The placental tissue structure is very permissive to RF energy, which suggests that RF could be used for the ablation of retained placenta, providing optimal control of tissue destruction. These results call for further experimental evaluations.
Morel
O
O
Obstetrics and Gynaecology Unit, Lariboisière Hospital, 2 Rue A. Paré, Paris, France.
Monceau
E
E
Tran
N
N
Malartic
C
C
Morel
F
F
Barranger
E
E
Côté
J F
JF
Gayat
E
E
Chavatte-Palmer
P
P
Cabrol
D
D
Tsatsaris
V
V
D000818:Animals; D017115:Catheter Ablation / Q000379:methods* / Q000592:standards; D005260:Female; D006358:Hot Temperature / Q000627:therapeutic use; D006801:Humans; D010920:Placenta / Q000601:surgery*; D010921:Placenta Accreta / Q000473:pathology / Q000601:surgery*; D011247:Pregnancy; D012016:Reference Values; D015203:Reproducibility of Results; D012756:Sheep